RecruitingNot ApplicableNCT05168605
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Sponsor
University of Texas Southwestern Medical Center
Enrollment
100 participants
Start Date
Jul 27, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Inclusion Criteria5
- Adult patients ages 18-60
- Spanish or English speaking
- Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record)
- Hemoglobin A1C\>8 in last 6 months (based on medical record)
- Not pregnant
Exclusion Criteria3
- Current oral steroid use
- History of solid organ transplant
- Language other than English or Spanish
Interventions
OTHERHome visit
Patients receiving home Visits
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05168605
Related Trials
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT0729648446 locations
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
NCT068364791 location
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location